Skip to main content

4 Result(s)

within Pei-Hua Luo Remove this filter

and

  1. No Access

    Article

    Effects of unidentified renal insufficiency on the safety and efficacy of chemotherapy for metastatic colorectal cancer patients: a prospective, observational study

    This is a single-center, prospective, observational study aiming to determine the effects of unidentified renal insufficiency (URI) on the safety and efficacy of chemotherapy for metastatic colorectal cancer (...

    Jian Chen, **ao-ting Wang, Pei-hua Luo, Qiao-jun He in Supportive Care in Cancer (2015)

  2. No Access

    Article

    Preclinical studies of targeted therapies for CD20-positive B lymphoid malignancies by Ofatumumab conjugated with auristatin

    Utilization of antibodies to deliver highly potent cytotoxic agents to corresponding antigen-overexpressed tumor cells is a clinically validated therapeutic strategy. Ofatumumab (OFA, trade name Arzerra) is a ...

    Zhao Hui Li, Qian Zhang, Hai Bin Wang, Ya Nan Zhang, Ding Ding… in Investigational New Drugs (2014)

  3. Article

    Erratum to: Antimetastatic activity of MONCPT in preclinical melanoma mice model

    **ao-Chun Yang, Chong-**ng Tu, Pei-Hua Luo, Hong Zhu… in Investigational New Drugs (2010)

    Download PDF (50 KB) View Article

  4. No Access

    Article

    Antimetastatic activity of MONCPT in preclinical melanoma mice model

    Previous study demonstrated that MONCPT, a topoisomerase I inhibitor, exhibited potent anti-proliferation and anti-angiogenesis activity in vitro and in vivo. In this study, we report the efficacy of MONCPT ag...

    **ao-Chun Yang, Chong-**ng Tu, Pei-Hua Luo, Hong Zhu… in Investigational New Drugs (2010)